Covestor
COGT icon

Covestor’s Cogent Biosciences COGT Stock Holding History

Covestor’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11K Buy
335
+29
+9% +$1.07K 0.01% 1378
2026
Q2 		$12K Buy
306
+36
+13% +$1.26K 0.01% 1417
2026
Q1 		$10K Buy
270
+252
+1,400% +$9.3K 0.01% 1386
2025
Q4 		$1K Hold
18
– – ﹤0.01% 2015
2025
Q3 		$0 Hold
18
– – ﹤0.01% 2341
2025
Q2 		$0 Buy
18
+7
+64% +$39 ﹤0.01% 2275
2025
Q1 		$0 Hold
11
– – ﹤0.01% 2287
2024
Q4 		$0 Buy
11
+1
+10% +$10 ﹤0.01% 2294
2024
Q3 		$0 Sell
10
-1
-9% -$10 ﹤0.01% 2282
2024
Q2 		$0 Hold
11
– – ﹤0.01% 2296
2024
Q1 		$0 Sell
11
-4
-27% -$25 ﹤0.01% 2297
2023
Q4 		$0 Buy
15
+8
+114% +$61 ﹤0.01% 2205
2023
Q3 		$0 Sell
7
-1
-13% -$12 ﹤0.01% 2177
2023
Q2 		$0 Hold
8
– – ﹤0.01% 2189
2023
Q1 		$0 Hold
8
– – ﹤0.01% 2084
2022
Q4 		$0 Buy
+8
New +$99 ﹤0.01% 2117

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Covestor's COGT Position: Q3 2026 in Review

Covestor increased its Cogent Biosciences (COGT) stake by 9.5% in Q3 2026, buying an estimated $1.07K and bringing the position to 335 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #1378.

Covestor first reported a position in COGT in Q4 2022 and has held it in 16 quarters since. The position peaked at $12K in Q2 2026. 202 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • Covestor held 335 shares of Cogent Biosciences worth $11K as of Q3 2026.
  • Covestor bought 29 Cogent Biosciences shares in Q3 2026, an estimated $1.07K.
  • Cogent Biosciences made up 0.01% of Covestor's portfolio in Q3 2026, its #1378 holding.
  • Covestor first reported a position in Cogent Biosciences in Q4 2022 and has held it in 16 quarters since.
  • Covestor's Cogent Biosciences position peaked at $12K in Q2 2026.
  • 202 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.